| Affiliation: | 1. Genomic Instability Group, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain;2. Transgenics Unit, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain;3. Science for Life Laboratory, Division of Translational Medicine and Chemical Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, 171 21 Stockholm, Sweden;1. CeMM Research Center for Molecular Medicine of the Austrian Academy of Science, Vienna, Austria;2. Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA;3. Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical, Boston, USA;1. Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, UK;2. Boehringer Ingelheim RCV GmbH & Co KG, Dr. Boehringer Gasse 5-11, A-1121, Vienna, Austria;1. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria;1. Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Tongjiaxiang 24, Nanjing, 210009, China;2. Department of Medicinal Chemistry, China Pharmaceutical University, Tongjiaxiang 24, Nanjing, 210009, China |
